Bipolar Disorder Clinical Trials

Showing 241-260 of 605 trials

Utility of the Pharmacogenetic Information Provided by NEUROPHARMAGEN in the Treatment of Bipolar Depressionwith Bipolar Depression

NCT04923204

Evaluation of the impact of the genetic variation of individual genes on the therapeutic response and side effects profile in a cohort of well-characterized patients with bipolar depression, using NEUROPHARMAGEN.

Bipolar Disorder

AB Biotics, SA76 participantsStarted Mar 2016

Barcelona, Spain

UNKNOWNPhase 1/2

Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2

NCT04846010

Post-acute sequelae of SARS-CoV-2 infection can cause multiple system function disorders, and complicated symptoms last for an extended period. The virus can cause this continued infection, or the virus causes immune system function disorder and post-infectious autoimmune disease. The clinical symptoms can be smell loss, taste loss to liver function disorder, kidney function failure, different. No matter how complicated the systems showed in the clinic, all of the symptoms are due to the specific cells being damaged. Our clinical study is focused on recovering the damaged structure and function of the cells that could restore the organ function back to normal or close to normal

Sequelae of; InfectionPost Infection GlomerulonephritisPost-Infectious Peripheral Neuralgia+15 more

All Natural Medicine Clinic, LLC2,000 participantsStarted Mar 2021

Rockville, Maryland, United States

Utility of the Pharmacogenetic Information Provided by NEUROPHARMAGEN in the Treatment of Bipolar Depressionwith Bipolar Depression

Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2

Related Searches

Comparison of Physical and Virtual Sensory Room in an Inpatient Setting

Features Emotional Responses in Adults With Autism: Comparison With Bipolar Disorder (REMBAU)

Bio-equivalence Study Between SAPHRIS and Asenapine

Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)

Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome

A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule

Community-based Mental Health Care for People With Severe and Enduring Mental III Health

Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)

BIMET Study: Evolution of Metabolic and Cardiovascular Risks Factors in Patients With Bipolar Disorder

Brief Motivational Intervention to Improve Medication Adherence for Adolescents With Bipolar Disorder

Identification of Predictive Biomarkers of Mood Relapses in Patients With Bipolar Disorder

Treating Insulin Resistance as a Strategy to Improve Outcome in Refractory Bipolar Disorder

Study to Promote Innovation in Rural Integrated Telepsychiatry

Management of my Bipolarity Intervention in Bipolar Disorder Patients

Cost- Effectiveness and Quality of Life Assessment in Mood Disorder